H1 antihistamine + mast cell stabiliser
Olopatadine
Brand names: Opatanol, Patanase
Adult dose
Dose: Eye drops 0.1%: 1 drop BD. Nasal spray: 2 sprays each nostril BD
Route: Topical/Nasal
Frequency: BD
Clinical pearls
- Allergic conjunctivitis, allergic rhinitis
Contraindications
- Hypersensitivity
Side effects
- Local irritation
- Bitter taste (nasal)
- Headache
Reference: BNF; BSACI; https://bnf.nice.org.uk/drugs/olopatadine/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Urticaria Activity Score (UAS7) · Urticaria
- C-Peptide to Glucose Ratio · Diabetes Classification
- IMDC (Heng) Score for Metastatic RCC · Renal Cell Carcinoma
- International Prognostic Index (IPI) for DLBCL · Lymphoma
- IMDC Risk Model for Metastatic Renal Cell Carcinoma · Cancer Prognosis
- HCT-CI — Haematopoietic Cell Transplant Comorbidity Index · Risk Stratification
Pathways
- Acute Red Eye / Vision Loss Screen · RCOphth 2020; NICE CKS
- Idiopathic Intracranial Hypertension · ABN; consensus 2018
- Acute Red Eye Assessment · RCOphth / AAO
- Acute Angle Closure Glaucoma · RCOphth / EGS Guidelines
- Retinal Detachment · RCOphth Guidelines / EURETINA
- Diabetic Retinopathy — Screening and Management · NICE NG28 2016 / NHS DES Programme